Medtech Insight spoke with Leads.Healthcare’s Ben Modley about Germany’s evolving NUBs reimbursement scheme for innovative medical technologies, and the status of the fast-tracking scheme for promising yet not-fully-proven technologies for use in the ambulatory setting. Changes have been made to the former, while the latter at last appears to be on the cusp of some solid progress.
